Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: A quasi-randomised study assessing impact on length of stay and antimicrobial use

BMC Infectious Diseases

Volumn 17, Issue 1, 2017, Pages

  Andrews, Denise ^a   Chetty, Yumela ^a   Cooper, Ben S ^b,c   Virk, Manjinder ^a   Glass, Stephen K ^a   Letters, Andrew ^a   Kelly, Philip A ^a   Sudhanva, Malur ^a   Jeyaratnam, Dakshika ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Adults; Antimicrobial stewardship; FilmArray ; Length of stay; Multiplex PCR; Point of care; Respiratory pathogens; Respiratory tract infection; Respiratory viruses

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CAUSE OF DEATH; COMPLEMENT FIXATION TEST; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; FLU LIKE SYNDROME; HOSPITAL DEPARTMENT; HOSPITAL READMISSION; HUMAN; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INTERMETHOD COMPARISON; LABORATORY TEST; LENGTH OF STAY; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MICROORGANISM DETECTION; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOPLASMOSIS; NONHUMAN; NOSE SMEAR; OUTPATIENT DEPARTMENT; POINT OF CARE TESTING; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; THROAT CULTURE; TREATMENT OUTCOME; TURNAROUND TIME; UPPER RESPIRATORY TRACT INFECTION; GENETICS; HOSPITALIZATION; INFLUENZA; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UTILIZATION;

AGED; ANTI-INFECTIVE AGENTS; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA, HUMAN; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; POINT-OF-CARE TESTING; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES;

EID: 85030847471     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-017-2784-z     Document Type: Article

References (30)

1. Surveillance of influenza and other respiratory viruses, including novel respiratory viruses, in the United Kingdom: winter 2012/13, Public Health England. http://webarchive.nationalarchives.gov.uk/20140714084352/http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317139321787 Accessed on 15 Mar 2017.
2. Musher DM, Thorner AR. Community-acquired pneumonia. N Engl J Med. 2015;372(3):294.
3. Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, Macfarlane JT, Read RC, Roberts HJ, Levy ML, Wani M, Woodhead MA. Guidelines for the Management of Community Acquired Pneumonia in adults: update 2009. Thorax 2009. Volume 64. Supplement III.
4. Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TS, Al Mamun A, et al. PRIDE Consortium Investigators. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza a H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med. 2014;2(5):395-404.
5. WHO Antimicrobial resistance fact sheet http://www.who.int/mediacentre/factsheets/fs194/en/ Accessed on 14 Dec 2016.
6. Pluddemann A, Onakpoya I, Harrison S, Shinkins B, Tompson A, Davis R, et al. Position paper on anti-microbial resistance diagnostics - Centre for Evidence-Based Medicine. Oxford: University of Oxford June 2015. http://www.cebm.net/wp-content/uploads/2015/07/AMR-Diagnostic-technologies_10-June-2015.pdf Accessed on 15 Mar 2017.
7. Centers for Disease Control and Prevention. Rapid diagnostic testing for influenza: information for health care professionals. Page last updated: August 4, 2016. http://www.cdc.gov/flu/professionals/diagnosis/rapidclin.htm. Accessed on 8 Sept 2016.
8. Clark NM, Lynch JP 3rd. Influenza: epidemiology, clinical features, therapy, and prevention. Semin Respir Crit Care Med. 2011;32(4):373-92.
9. Poritz MA, Blaschke AJ, Byington CL, Meyers L, Nilsson K, Jones DE, et al. FilmArray, an automated nested multiplex PCR system for multi-pathogen detection: development and application to respiratory tract infection. PLoS One. 2011;6(10):e26047. https://doi.org/10.1371/annotation/468cfdcd-184c-42f7-a1d0-3b72a2f6a558.
10. Auburn H, Zuckerman M, Broughton S, Greenough A, Smith M. Detection of nine respiratory RNA viruses using three multiplex RT-PCR assays incorporating a novel RNA internal control transcript. J Virol Methods. 2011 Sep;176(1-2):9-13.
11. Heim A, Ebnet C, Harste G, Pring-Akerblom P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol. 2003;70(2):228-39.
12. CDC protocol of real-time RTPCR for influenza a(H1N1) 28 April 2009 revision 1 (30 April 2009) revision 2 (6 October 2009) http://www.who.int/csr/resources/publications/swineflu/CDCRealtimeRTPCR_SwineH1Assay-2009_20090430.pdf?ua=1 Accessed on 06 Feb 2017.
13. https://www.cdc.gov/flu/keyfacts.htm last accessed 9 Aug 2017.
14. Guest JF, Morris A. Community-acquired pneumonia: the annual cost to the National Health Service in the UK. Eur Respir J. 1997;10:1530-4.
15. Merchant S, Mullins CD, Shih YC. Factors associated with hospitalization costs for patients with community-acquired pneumonia. Clin Ther. 2003;25(2):593-610.
16. Royal College of Physicians. National Early Warning Score (NEWS): Standardising the assessment of acute illness severity in the NHS. Report of a working party. London: RCP, 2012. file:///C:/Users/dakshika%20jeyaratnam/Downloads/National%20Early%20Warning%20Score%20(NEWS)%20-%20Standardising%20the%20assessment%20of%20acute-illness%20severity%20in%20the%20NHS_0%20(1).pdf Accessed on 15 March 2017.
17. Perez K, Olsen RJ, Musick WL, Cernoch PL, Davis JR, Land GA, et al. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med. 2013 Sep;137(9):1247-54.
18. R Core Team (2015). R: a language and environment for statistical computing. R foundation for statistical computing, Vienna, Austria. https://www.R-project.org/.
19. Van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45(3):1-67. http://www.jstatsoft.org/v45/i03/
20. Wu PJ, Jeyaratnam D, Tosas O, Cooper BS, French GL. Point-of-care universal screening for meticillin-resistant Staphylococcus Aureus: a cluster-randomized cross-over trial. J Hosp Infect. 2017;95(3):245-52.
21. Brendish NJ, Malachira AK, Armstrong L, Houghton R, Aitken S, Nyimbili E, et al. Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial. Lancet Respir Med. 2017;5:401-11.
22. Xu M, Qin X, Astion ML, Rutledge JC, Simpson J, Jerome KR, et al. Implementation of Filmarray respiratory viral panel in a core laboratory improves testing turnaround time and patient care. Am J Clin Pathol. 2013;139(1):118-23.
23. Pettit N, Matushek S, Charnot-Katsikas A, Tesic V, Boonlayangoor S, Brielmaier B, et al. Comparison of turnaround time and time to oseltamivir discontinuation between two respiratory viral panel testing methodologies. J Med Microbiol. 2015;64(Pt 3):312-3.
24. Schulert GS, Lu Z, Wingo T, Tang YW, Saville BR, Hain PD. Role of a respiratory viral panel in the clinical management of pediatric inpatients. Pediatr Infect Dis J. 2013;32(5):467-72.
25. Rogers BB, Shankar P, Jerris RC, Kotzbauer D, Anderson EJ, Watson JR, et al. Impact of a rapid respiratory panel test on patient outcomes. Arch Pathol Lab Med. 2015;139:636.
26. Rappo U, Schuetz AN, Jenkins SG, Calfee DP, Walsh TJ, Wells MT, et al. Impact of early detection of respiratory viruses by multiplex PCR assay on clinical outcomes in adult patients. J Clin Microbiol. 2016;54(8):2096-103.
27. Gadsby NJ, Russell CD, McHugh MP, Mark H, Morris AC, Laurenson IF, et al. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis. 2016;62(7):817-23.
28. Gilbert D, Gelfer G, Wang L, Myers J, Bajema K, Johnston M, et al. The potential of molecular diagnostics and serum procalcitonin levels to change the antibiotic management of community-acquired pneumonia. Diagn Microbiol Infect Dis. 2016;86(1):102-7.
29. Gelfer G, Leggett J, Myers J, Wang L, Gilbert DN. The clinical impact of the detection of potential etiologic pathogens of community-acquired pneumonia. Diagn Microbiol Infect Dis. 2015;83(4):400-6.
30. House of Commons Committee of Public Accounts. Department of Health: improving emergency care in England. Sixteenth report of session 2004-05. Report, together with formal minutes, oral and written evidence. Ordered by The House of Commons to be printed 9 March 2005. http://www.publications.parliament.uk/pa/cm200405/cmselect/cmpubacc/445/445.pdf Accessed on 8 Sept 2016.